Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00311688 · ClinicalTrials.gov registry record
Umbrella Study for HIV Infected Adults Enrolled in NIAID-Funded Interleukin-2 Studies
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
NCT00311688 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID).
The verdict
NCT00311688 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
Study Summary
Interleukin-2 (IL-2) is a protein found naturally in the blood that helps boost the immune system. The purpose of this study is to provide long-term treatment and monitoring of HIV infected people enrolled in NIAID-funded studies investigating the use of laboratory-made IL-2 for the treatment of HIV infection.
Interventions
- DRUG Interleukin-2
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-12 |
| Est. Completion | 2008-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00311688
The ClinicalTrials.gov registry entry for NCT00311688 describes a study currently listed as completed, categorized as an unspecified phase. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Interleukin-2 is the first listed.
NCT00311688 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00311688 about?
NCT00311688 is a clinical study titled "Umbrella Study for HIV Infected Adults Enrolled in NIAID-Funded Interleukin-2 Studies". Interleukin-2 (IL-2) is a protein found naturally in the blood that helps boost the immune system. The purpose of this study is to provide long-term treatment and monitoring of HIV infected people enrolled in NIAID-funded studies investigating the use of laboratory-made IL-2 for the treatment of HIV...
What is the current status of trial NCT00311688?
This trial is currently completed. The study started on 2003-12. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00311688?
The interventions under investigation include: Interleukin-2 (DRUG).
Who is sponsoring clinical trial NCT00311688?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.